Oct. 11–12, 2021 • New York
View Schedule • Registration Rates • Register Now • Submit an AbstractDownload Program Flyer
The Society for Immunotherapy of Cancer (SITC) invites you to attend the workshop, Cytokines in Cancer Immunotherapy. This SITC workshop will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches.
It is anticipated that the efforts of this workshop will foster renewed exchange and research on the promising topic of cytokines and their interactions in cancer development and therapy, lead to further research, and provide a solid scientific foundation for future clinical interventions to modulate anti-tumor immunity with combinations of cytokines and other immunotherapies.
This program is intended for basic, translational and clinical researchers in academia and industry with a vested interest in the topic of cytokine immunology and the impact of cytokines in cancer immunotherapy.
VIEW ABSTRACT SUBMISSION GUIDE
Submit an Abstract
To receive the discounted hotel rates, reservations must be made before Sept. 10, 2021.
Reserve Your Hotel RoomNOTE: SITC will announce in early July 2021 if the meeting will be held virtually or in person.
SITC is actively monitoring the incidence of COVID-19 and how it may impact our workshops. At this time, SITC is planning to host this event live (in-person) in New York. We will continue to assess the feasibility and safety of a live event. In the instance an in-person meeting is not feasible, the workshop will shift to a virtual format. This decision will be announced in early July 2021, and should the need arise, registrants will have the option for a refund or to convert to a virtual registration.
CDC COVID Travel Guidelines
New York COVID Travel Advisory
If you have questions about this program, please contact the SITC Education team.
This program is supported, in part, by grants from Amgen Inc., Genentech, a member of the Roche Group, Nektar Therapeutics, and Pfizer, Inc. (As of 04/26/2021)
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com